Revance Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Hollander David
Revance Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-GIC Private Limited(0%)
Revance Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Capital World Investors(0.0%)
Revance Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Beryl Capital Management LLC(1.6%),Beryl Capital Management LP(1.6%), etc.
Revance Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Capital World Investors(6.6%)
Revance Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Foley Mark J
Revance Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Schilke Tobin
Revance Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Ware Olivia C
Revance Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Russell Angus C.
Revance Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Nolet Chris
Revance Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Kolaja Carey OConnor
Revance Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Gangolli Julian S
Revance Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Coric Vlad
Revance Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Beraud Jill
Revance Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Jordan Erica
Revance Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-JPMORGAN CHASE & CO.(2.6%)
Revance Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Sjuts Dustin S
Revance Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Moxie Dwight
Revance Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Schilke Tobin
Revance Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Foley Mark J